Breaking News
Investing Pro 0
🙌 It's Here: the Only Stock Screener You'll Ever Need Get Started

Republican lawmaker to grill U.S. SEC over Ackman tactics

Published Jul 24, 2014 12:10AM ET Updated Jul 24, 2014 12:20AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
AGN_pa
0.00%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
BHC
+0.37%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

By Sarah N. Lynch WASHINGTON (Reuters) - A U.S. lawmaker will pressure the U.S. Securities and Exchange Commission on Thursday to consider a raft of reforms, after William Ackman's aggressive efforts to take over Allergan Inc raised concerns about loose rules governing disclosure and shareholder voting.

Republican Representative Edward Royce of California plans to grill SEC Corporation Finance Director Keith Higgins at a House Financial Services hearing.

Among his top concerns is a rule that lets investors such as Ackman delay publicly reporting when they have amassed a large stake in a company for days.

"I am especially interested in the SEC's process when looking at novel or creative deals like the announced joint-bid by Valeant Pharmaceuticals and Pershing Square for Allergan," Royce said in a statement.

"Mr. Higgins' appearance before the committee is an opportunity to make sure that the Commission is making robust reviews of these sorts of deals to ensure strong investor protections and market transparency."

Saat Alety, Royce's spokesman, said that Royce is prepared to take legislative action if the SEC fails to fix the problem on its own.

UNUSUAL TACTICS

In recent months, Royce has been writing letters to the SEC to express concerns about some unusual maneuvers that Ackman's company Pershing Square Capital Management has used in its joint effort with Valeant Pharmaceuticals International Inc to win a $53 billion hostile takeover of Allergan, which is headquartered near Royce's California district.

In one May letter, Royce said he was concerned about early efforts by Ackman to call a non-binding shareholder vote outside of Allergan's typical election procedures as a way to pressure Allergan to negotiate a deal.

Royce said he feared this "shadow" election would make it tough for shareholders to "truly understand what is going on."

Pershing Square dropped plans for a shareholder referendum in May and has since pursued a more traditional proxy battle.

In a July 2 letter to Royce, SEC Chair Mary Jo White said that the Corporation Finance division will "continue to consider issues raised by the filing related to the abandoned shareholder referendum" and "issues raised by any future filings of a similar nature."

Ackman's tactics have raised a number of regulatory questions, both about his actions and about hostile takeover bids generally.

It has renewed calls to fix a SEC rule that affords large investors a 10-day delay before they must report when they have amassed more than a 5 percent stake in a company.

The 2010 Dodd-Frank law authorized the SEC to shorten the reporting period, but so far the SEC has not taken up the measure.

Higgins' division is in charge of reviewing financial statements of public companies and corporate governance matters.

In that role, his division would oversee a rule-writing on the reporting period and also review proxy filings and related regulatory matters.

Royce's questions on Thursday will touch on just one of what is expected to be a wide-ranging list of topics at the hearing.

Lawmakers also plan to ask Higgins about other matters, from rulemakings required by the Dodd Frank and JOBS Act laws, to how the SEC oversees proxy advisory firms.

(Reporting by Sarah N. Lynch; Editing by Lisa Shumaker)

Republican lawmaker to grill U.S. SEC over Ackman tactics
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email